Healthcare & Life Sciences Industry Updates

Google News – Clinical Trials External News

FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease - Biogen

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

Massive Bio Announces Partnership with Sequence Me Now to Help Cancer Patients Access Clinical Trials - Business Wire

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

Digital Twins Are Rewriting Clinical Trial Math. The Validation Problem Could Erase the Gains. - The Clinical Trial Vanguard

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

Alkermes releases nine-month data as OX2R race heats up - Clinical Trials Arena

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule - Clinical Trials Arena

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

Novo Nordisk reports Phase III FRONTIER4 study results for denecimig - Clinical Trials Arena

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

Serina concludes sentinel dosing in Phase Ib trial’s Cohort 1 - Clinical Trials Arena

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

GSK’s partner Hansoh Pharma succeeds in Chinese Phase III SCLC ADC trial - Clinical Trials Arena

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

Real-World Data Confirm Alectinib's Edge Over Crizotinib in ALK+ NSCLC - Targeted Oncology

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

FDA approves clinical testing of CAR T-cell therapy for AAV, other conditions - ANCA Vasculitis News

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

Can Removing "Zombie Cells" Slow Aging? Human Clinical Trials Are Starting to Deliver Answers - Medical Daily

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

Ibuprofen safely dampens inflammatory markers in 28-patient drug-resistant tuberculosis trial - Medical Xpress

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

When Your CRO Merges Mid-Study, the Site Pays the Price - The Clinical Trial Vanguard

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab - Pharmaceutical Executive

news.google.com · 14 Jul 2026

Google News – Clinical Trials External News

Q&A: Understanding Relacorilant’s Emerging Role in Platinum-Resistant Ovarian Cancer - Physician's Weekly

news.google.com · 14 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease - Biogen

Massive Bio Announces Partnership with Sequence Me Now to Help Cancer Patients Access Clinical Trials - Business Wire

Digital Twins Are Rewriting Clinical Trial Math. The Validation Problem Could Erase the Gains. - The Clinical Trial Vanguard

Alkermes releases nine-month data as OX2R race heats up - Clinical Trials Arena

“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule - Clinical Trials Arena

Novo Nordisk reports Phase III FRONTIER4 study results for denecimig - Clinical Trials Arena

Serina concludes sentinel dosing in Phase Ib trial’s Cohort 1 - Clinical Trials Arena

GSK’s partner Hansoh Pharma succeeds in Chinese Phase III SCLC ADC trial - Clinical Trials Arena

Real-World Data Confirm Alectinib's Edge Over Crizotinib in ALK+ NSCLC - Targeted Oncology

FDA approves clinical testing of CAR T-cell therapy for AAV, other conditions - ANCA Vasculitis News

Can Removing "Zombie Cells" Slow Aging? Human Clinical Trials Are Starting to Deliver Answers - Medical Daily

Ibuprofen safely dampens inflammatory markers in 28-patient drug-resistant tuberculosis trial - Medical Xpress

When Your CRO Merges Mid-Study, the Site Pays the Price - The Clinical Trial Vanguard

FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab - Pharmaceutical Executive

Q&A: Understanding Relacorilant’s Emerging Role in Platinum-Resistant Ovarian Cancer - Physician's Weekly